Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis.

ABSTRACT:

Background

With the emergence of disease-modifying Alzheimer's treatments, timely detection of early-stage disease is more important than ever, as the treatment will not be indicated for later stages. Contemporary population-level data for detection rates of mild cognitive impairment (MCI), the stage at which treatment would ideally start, are lacking, and detection rates for dementia are only available for subsets of the Medicare population. We sought to compare documented diagnosis rates of MCI and dementia in the full Medicare population with expected rates based on a predictive model.

Methods

We performed an observational analysis of Medicare beneficiaries aged 65 and older with a near-continuous enrollment over a 3-year observation window or until death using 100% of th

SUBMITTER: Mattke S 

PROVIDER: S-EPMC10362635 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature